Expression of Vascular Endothelial Growth Factor and Proliferation Marker MIB1 Are Influenced by Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Growth Factor ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Vascular Endothelial ◽

Proliferation Marker ◽

31P S-Vegf (Vascular Endothelial Growth Factor) as Predictive Factor in Response to Anthracycline Based Chemotherapy in Patients with Locally Advanced Breast Cancer

Annals of Oncology ◽

10.1016/s0923-7534(19)65677-2 ◽

2012 ◽

Vol 23 ◽

pp. ii23

Author(s):

D. Arya ◽

B.J. Parikh ◽

P.M. Shah ◽

S.N. Shukla ◽

K.M. Patel ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Advanced Breast Cancer ◽

Predictive Factor ◽

Locally Advanced ◽

Advanced Breast ◽

Vascular Endothelial ◽

Evaluation of Lymphangiogenic Factors, Vascular Endothelial Growth Factor D and E-Cadherin in Distinguishing Inflammatory From Locally Advanced Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2012.04.005 ◽

2012 ◽

Vol 12 (4) ◽

pp. 232-239 ◽

Cited By ~ 10

Author(s):

Paul H. Levine ◽

Chia C. Portera ◽

Heather J. Hoffman ◽

Sherry X. Yang ◽

Mikiko Takikita ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

E Cadherin

Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial Of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

Yearbook of Oncology ◽

10.1016/s1040-1741(09)79334-0 ◽

2009 ◽

Vol 2009 ◽

pp. 11-12

Author(s):

J.T. Thigpen

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Advanced Breast Cancer ◽

Genetic Polymorphisms ◽

Growth Factor Receptor ◽

Advanced Breast ◽

Vascular Endothelial ◽

Race to Report: Are Vascular Endothelial Growth Factor Genetic Polymorphisms Associated With Outcome in Advanced Breast Cancer Patients Treated With Paclitaxel Plus Bevacizumab?

Journal of Clinical Oncology ◽

10.1200/jco.2008.20.6359 ◽

2009 ◽

Vol 27 (8) ◽

pp. 1342-1342 ◽

Cited By ~ 1

Author(s):

Tan Min-Han ◽

Tan Chuen Seng ◽

Lim Wei Yen

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Genetic Polymorphisms ◽

Advanced Breast ◽

Vascular Endothelial ◽

Breast Cancer Patients ◽

Faculty Opinions recommendation of Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1123035.580146 ◽

2008 ◽

Author(s):

Philippe Van Trappen

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Advanced Breast Cancer ◽

Genetic Polymorphisms ◽

Growth Factor Receptor ◽

Advanced Breast ◽

Vascular Endothelial ◽

Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

Molecular and Cellular Biochemistry ◽

10.1007/s11010-017-3244-1 ◽

2017 ◽

Vol 444 (1-2) ◽

pp. 197-206 ◽

Cited By ~ 2

Author(s):

Nataliya Babyshkina ◽

Marina Zavyalova ◽

Natalia Tarabanovskaya ◽

Tatyana Dronova ◽

Nadejda Krakhmal ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Triple Negative ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Breast Cancer Patients ◽

High Ki-67 and Vascular Endothelial Growth Factor (VEGF) Protein Expression as Negative Predictive Factor for Combined Neoadjuvant Chemotherapy in Young Age Stage III Breast Cancer

Bali Medical Journal ◽

10.15562/bmj.v5i2.207 ◽

2016 ◽

Vol 5 (2) ◽

pp. 35 ◽

Cited By ~ 1

Author(s):

I Wayan Sudarsa ◽

Ida Bagus Tjakra Wibawa Manuaba ◽

Sri Maliawan ◽

I Wayan Putu Sutirtayasa

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Vascular Endothelial ◽

Ki 67 ◽

Stage Iii Breast Cancer ◽

Endothelial Growth Factor ◽

Negative Predictive Factor ◽

Vegf Protein

A Pilot Study to Evaluate the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor AZD2171 and Chemotherapy in Locally Advanced and Inflammatory Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2005.n.052 ◽

2005 ◽

Vol 6 (5) ◽

pp. 460-463 ◽

Cited By ~ 3

Author(s):

Neelima Denduluri ◽

Antoinette R. Tan ◽

Janice Walshe ◽

Arlene Berman ◽

Sherry X. Yang ◽

...

Keyword(s):

Breast Cancer ◽

Pilot Study ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Docetaxel, doxorubicin and cyclophospharmide as neoadjuvant chemotherapy with primary prophylactic stem cell growth factor support in locally advanced breast cancer (T3 – T4 , No – 3, Mo)

Research in Oncology ◽

10.21608/resoncol.2006.354 ◽

2006 ◽

Vol 2 (2) ◽

pp. 1-6

Author(s):

Ehab Elnakory ◽

Samiah Abdulrazek ◽

Ashraf Fawzy

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Growth Factor ◽

Cell Growth ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Stem Cell Growth Factor

Abstract P1-08-26: Hypertension and phosphorylated vascular endothelial growth factor receptor 2 are potential independent predictive factors for progession-free survival in apatinib-treated advanced breast cancer

10.1158/0008-5472.sabcs13-p1-08-26 ◽

2013 ◽

Author(s):

M Fan ◽

X Hu ◽

J Zhang ◽

Z Wang ◽

Q Zhang

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Advanced Breast Cancer ◽

Predictive Factors ◽

Growth Factor Receptor ◽

Advanced Breast ◽

Vascular Endothelial ◽

Free Survival ◽